XL-413 is a drug which acts as a selective inhibitor of the enzyme cell division cycle 7-related protein kinase (CDC7). It is being researched for the treatment of some forms of cancer, and also has applications in genetic engineering.
References
Wikipedia
XL-413
Tags
- Antineoplastic and immunomodulating drug stubs
- Bioengineering stubs
- Chloroarenes
- Enzyme inhibitors
- Experimental cancer drugs
- Genetic engineering
- Genetics stubs
- Pyrimidones
- Pyrrolidines